Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2
Open Access
- 1 December 2008
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 10 (6) , 981-994
- https://doi.org/10.1215/15228517-2008-048
Abstract
Candidate gene investigations have indicated a significant role for epigenetic events in the pathogenesis of medulloblastoma, the most common malignaKeywords
This publication has 43 references indexed in Scilit:
- Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastomaBritish Journal of Cancer, 2007
- Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma1Neuro-Oncology, 2007
- Nodule Formation and Desmoplasia in Medulloblastomas—Defining the Nodular/Desmoplastic Variant and Its Biological BehaviorBrain Pathology, 2007
- The quantitative trait gene latexin influences the size of the hematopoietic stem cell population in miceNature Genetics, 2007
- Wnt/Wingless Pathway Activation and Chromosome 6 Loss Characterise a Distinct Molecular Sub-Group of Medulloblastomas Associated with a Favourable PrognosisCell Cycle, 2006
- Fibroblasts in cancerNature Reviews Cancer, 2006
- Comprehensive genomic analysis of desmoplastic medulloblastomas: identification of novel amplified genes and separate evaluation of the different histological componentsThe Journal of Pathology, 2006
- β-Catenin Status Predicts a Favorable Outcome in Childhood Medulloblastoma: The United Kingdom Children's Cancer Study Group Brain Tumour CommitteeJournal of Clinical Oncology, 2005
- Identification and investigation of methylated genes in hepatomaEuropean Journal Of Cancer, 2005
- A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancerNature Genetics, 2002